{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:26:26Z","timestamp":1790799986341,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21H05278"],"award-info":[{"award-number":["JP21H05278"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K15736"],"award-info":[{"award-number":["JP22K15736"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25H00007"],"award-info":[{"award-number":["JP25H00007"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23bm1123046"],"award-info":[{"award-number":["JP23bm1123046"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23kk0305024"],"award-info":[{"award-number":["JP23kk0305024"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25ek0109811"],"award-info":[{"award-number":["JP25ek0109811"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21wm0425009"],"award-info":[{"award-number":["JP21wm0425009"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22bm0804003"],"award-info":[{"award-number":["JP22bm0804003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22ek0109616"],"award-info":[{"award-number":["JP22ek0109616"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23bm1423002"],"award-info":[{"award-number":["JP23bm1423002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25wm0625519"],"award-info":[{"award-number":["JP25wm0625519"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UBE Academic Foundation"},{"name":"the Kato Memorial Trust for Nambyo Research"},{"name":"Japan Intractable Diseases\uff08Nanbyo\uff09Research Foundation","award":["2024A04"],"award-info":[{"award-number":["2024A04"]}]},{"DOI":"10.13039\/501100003844","name":"Inamori Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018456","name":"Kanagawa Institute of Industrial Science and Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018456","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm Regener"],"DOI":"10.1186\/s41232-026-00404-w","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T08:59:15Z","timestamp":1769677155000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diagnostic potential of cryptic exon-derived peptides in serum extracellular vesicles for sporadic amyotrophic lateral sclerosis"],"prefix":"10.1186","volume":"46","author":[{"given":"Koki","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiho","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiko","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuko","family":"Moritoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7482-5935","authenticated-orcid":false,"given":"Hideyuki","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"404_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","volume":"22","author":"RJ Mead","year":"2023","unstructured":"Mead RJ, Shan N, Reiser HJ, Marshall F, Shaw PJ. Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nat Rev Drug Discov. 2023;22:185\u2013212. https:\/\/doi.org\/10.1038\/s41573-022-00612-2.","journal-title":"Nat Rev Drug Discov"},{"key":"404_CR2","doi-asserted-by":"publisher","unstructured":"Vasta R, De Mattei F, Tafaro S, Canosa A, Manera U, Grassano M, et al. Changes to average survival of patients with amyotrophic lateral sclerosis (1995\u20132018). Neurology 2025;104. https:\/\/doi.org\/10.1212\/WNL.0000000000213467.","DOI":"10.1212\/WNL.0000000000213467"},{"key":"404_CR3","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/17482960802566824","volume":"10","author":"A Chi\u00f2","year":"2009","unstructured":"Chi\u00f2 A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10:310\u201323. https:\/\/doi.org\/10.3109\/17482960802566824.","journal-title":"Amyotroph Lateral Scler"},{"key":"404_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117054","volume":"417","author":"D Richards","year":"2020","unstructured":"Richards D, Morren JA, Pioro EP. Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis. J Neurol Sci. 2020;417:117054. https:\/\/doi.org\/10.1016\/j.jns.2020.117054.","journal-title":"J Neurol Sci"},{"key":"404_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00685-6","volume":"19","author":"KE Irwin","year":"2024","unstructured":"Irwin KE, Sheth U, Wong PC, Gendron TF. Fluid biomarkers for amyotrophic lateral sclerosis: a review. Mol Neurodegener. 2024;19:9. https:\/\/doi.org\/10.1186\/s13024-023-00685-6.","journal-title":"Mol Neurodegener"},{"key":"404_CR6","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","volume":"79","author":"S-C Ling","year":"2013","unstructured":"Ling S-C, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79:416\u201338. https:\/\/doi.org\/10.1016\/j.neuron.2013.07.033.","journal-title":"Neuron"},{"key":"404_CR7","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1126\/science.aab0983","volume":"349","author":"JP Ling","year":"2015","unstructured":"Ling JP, Pletnikova O, Troncoso JC, Wong PC. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science. 2015;349:650\u20135. https:\/\/doi.org\/10.1126\/science.aab0983.","journal-title":"Science"},{"key":"404_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41593-018-0300-4","volume":"22","author":"JR Klim","year":"2019","unstructured":"Klim JR, Williams LA, Limone F, Guerra San Juan I, Davis-Dusenbery BN, Mordes DA, et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat Neurosci. 2019;22:167\u201379. https:\/\/doi.org\/10.1038\/s41593-018-0300-4.","journal-title":"Nat Neurosci"},{"key":"404_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41586-022-04424-7","volume":"603","author":"XR Ma","year":"2022","unstructured":"Ma XR, Prudencio M, Koike Y, Vatsavayai SC, Kim G, Harbinski F, et al. TDP-43 represses cryptic exon inclusion in the FTD\u2013ALS gene UNC13A. Nature. 2022;603:124\u201330. https:\/\/doi.org\/10.1038\/s41586-022-04424-7.","journal-title":"Nature"},{"issue":"8","key":"404_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.70183","volume":"169","author":"H Asano","year":"2025","unstructured":"Asano H, Kawaguchi T, Kato C, Morimoto S, Yano M, Minaguchi M, et al. Ropinirole functions through a dopamine receptor D2-independent mechanism to ameliorate amyotrophic lateral sclerosis phenotypes in TARDBP-mutant iPSC-derived motor neurons. J Neurochem. 2025;169(8):e70183. https:\/\/doi.org\/10.1111\/jnc.70183.","journal-title":"J Neurochem"},{"key":"404_CR11","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41591-023-02788-5","volume":"30","author":"KE Irwin","year":"2024","unstructured":"Irwin KE, Jasin P, Braunstein KE, Sinha IR, Garret MA, Bowden KD, et al. A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS\u2013FTD. Nat Med. 2024;30:382\u201393. https:\/\/doi.org\/10.1038\/s41591-023-02788-5.","journal-title":"Nat Med"},{"key":"404_CR12","doi-asserted-by":"publisher","unstructured":"Seddighi S, Qi YA, Brown A-L, Wilkins OG, Bereda C, Belair C, et al. Mis-spliced transcripts generate de novo proteins in TDP-43\u2013related ALS\/FTD. Sci Transl Med 2024;16. https:\/\/doi.org\/10.1126\/scitranslmed.adg7162.","DOI":"10.1126\/scitranslmed.adg7162"},{"key":"404_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/life13010121","volume":"13","author":"G McCluskey","year":"2022","unstructured":"McCluskey G, Morrison KE, Donaghy C, Rene F, Duddy W, Duguez S. Extracellular vesicles in amyotrophic lateral sclerosis. Life. 2022;13:121. https:\/\/doi.org\/10.3390\/life13010121.","journal-title":"Life"},{"key":"404_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01735-1","volume":"9","author":"MA Kumar","year":"2024","unstructured":"Kumar MA, Baba SK, Sadida HQ, Marzooqi SAl, Jerobin J, Altemani FH, et al. Extracellular vesicles as tools and targets in therapy for diseases. Signal Transduct Target Ther. 2024;9:27. https:\/\/doi.org\/10.1038\/s41392-024-01735-1.","journal-title":"Signal Transduct Target Ther"},{"key":"404_CR15","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/s41591-024-02937-4","volume":"30","author":"M Chatterjee","year":"2024","unstructured":"Chatterjee M, \u00d6zdemir S, Fritz C, M\u00f6bius W, Kleineidam L, Mandelkow E, et al. Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS. Nat Med. 2024;30:1771\u201383. https:\/\/doi.org\/10.1038\/s41591-024-02937-4.","journal-title":"Nat Med"},{"key":"404_CR16","doi-asserted-by":"publisher","unstructured":"Chizari S, Zanovello M, Kong S, Saigal V, Brown A-L, Turchetti V, et al. TDP-43 pathology induces CD8 + T cell activation through cryptic epitope recognition 2025. https:\/\/doi.org\/10.1101\/2025.06.22.660773.","DOI":"10.1101\/2025.06.22.660773"},{"key":"404_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/tjem.tjem_182_23","volume":"23","author":"\u015eK \u00c7orbac\u0131o\u011flu","year":"2023","unstructured":"\u00c7orbac\u0131o\u011flu \u015eK, Aksel G. Receiver operating characteristic curve analysis in diagnostic accuracy studies. Turk J Emerg Med. 2023;23:195\u20138. https:\/\/doi.org\/10.4103\/tjem.tjem_182_23.","journal-title":"Turk J Emerg Med"},{"key":"404_CR18","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1212\/WNL.0000000000001642","volume":"84","author":"C-H Lu","year":"2015","unstructured":"Lu C-H, Macdonald-Wallis C, Gray E, Pearce N, Petzold A, Norgren N, et al. Neurofilament light chain. Neurology. 2015;84:2247\u201357. https:\/\/doi.org\/10.1212\/WNL.0000000000001642.","journal-title":"Neurology"},{"key":"404_CR19","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.117.029443","volume":"137","author":"J Jacob","year":"2018","unstructured":"Jacob J, Ngo D, Finkel N, Pitts R, Gleim S, Benson MD, et al. Application of large-scale aptamer-based proteomic profiling to planned myocardial infarctions. Circulation. 2018;137:1270\u20137. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.029443.","journal-title":"Circulation"},{"issue":"1","key":"404_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62004-5","volume":"16","author":"IR Sinha","year":"2025","unstructured":"Sinha IR, Sandal PS, Spence H, Burns GD, Mallika AP, Abbasinejad F, et al. Large-scale RNA-Seq mining reveals ciclopirox olamine induces TDP-43 cryptic exons. Nat Commun. 2025;16(1):6878.","journal-title":"Nat Commun"},{"key":"404_CR21","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1111\/cns.13038","volume":"24","author":"Q Tao","year":"2018","unstructured":"Tao Q, Wei Q, Song S, Yin X. Motor neuron disease-like phenotype associated with anti-IgLON5 disease. CNS Neurosci Ther. 2018;24:1305\u20138. https:\/\/doi.org\/10.1111\/cns.13038.","journal-title":"CNS Neurosci Ther"},{"key":"404_CR22","doi-asserted-by":"publisher","unstructured":"Werner J, Jelcic I, Schwarz EI, Probst-M\u00fcller E, Nilsson J, Schwizer B, et al. Anti-IgLON5 Disease. Neurol Neuroimmunol Neuroinflamm 2021;8. https:\/\/doi.org\/10.1212\/NXI.0000000000000962.","DOI":"10.1212\/NXI.0000000000000962"},{"key":"404_CR23","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200153","author":"F Cluse","year":"2023","unstructured":"Cluse F, Hermier M, Demarquay G, Rogemond V, Mallaret M, Svahn J, et al. Trigeminal nerve involvement in bulbar-onset anti-IgLON5 disease. Neurol Neuroimmunol Neuroinflamm. 2023. https:\/\/doi.org\/10.1212\/NXI.0000000000200153.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"404_CR24","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.stem.2023.04.017","volume":"30","author":"S Morimoto","year":"2023","unstructured":"Morimoto S, Takahashi S, Ito D, Dat\u00e9 Y, Okada K, Kato C, et al. Phase 1\/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery. Cell Stem Cell. 2023;30:766-780.e9. https:\/\/doi.org\/10.1016\/j.stem.2023.04.017.","journal-title":"Cell Stem Cell"},{"key":"404_CR25","doi-asserted-by":"publisher","unstructured":"van Eijk RPA, Westeneng H-J, Nikolakopoulos S, Verhagen IE, van Es MA, Eijkemans MJC, et al. Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials. Neurology 2019;92. https:\/\/doi.org\/10.1212\/WNL.0000000000006855.","DOI":"10.1212\/WNL.0000000000006855"},{"key":"404_CR26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"L\u00f3pez-Ot\u00edn C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: an expanding universe. Cell. 2023;186:243\u201378. https:\/\/doi.org\/10.1016\/j.cell.2022.11.001.","journal-title":"Cell"},{"key":"404_CR27","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/s41586-025-08584-0","volume":"638","author":"T Guo","year":"2025","unstructured":"Guo T, Steen JA, Mann M. Mass-spectrometry-based proteomics: from single cells to clinical applications. Nature. 2025;638:901\u201311. https:\/\/doi.org\/10.1038\/s41586-025-08584-0.","journal-title":"Nature"},{"issue":"3","key":"404_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/jex2.35","volume":"1","author":"DE Gomes","year":"2022","unstructured":"Gomes DE, Witwer KW. L1CAM-associated extracellular vesicles: a systematic review of nomenclature, sources, separation, and characterization. J Extracell Biol. 2022;1(3):e35.","journal-title":"J Extracell Biol"},{"issue":"37","key":"404_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi3647","volume":"9","author":"Y You","year":"2023","unstructured":"You Y, Zhang Z, Sultana N, Ericsson M, Martens YA, Sun M, et al. ATP1A3 as a target for isolating neuron-specific extracellular vesicles from human brain and biofluids. Sci Adv. 2023;9(37):eadi3647. https:\/\/doi.org\/10.1126\/sciadv.adi3647.","journal-title":"Sci Adv"},{"key":"404_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.987655","volume":"13","author":"NH Thuesen","year":"2022","unstructured":"Thuesen NH, Klausen MS, Gopalakrishnan S, Trolle T, Renaud G. Benchmarking freely available HLA typing algorithms across varying genes, coverages and typing resolutions. Front Immunol. 2022;13:987655. https:\/\/doi.org\/10.3389\/fimmu.2022.987655.","journal-title":"Front Immunol"},{"key":"404_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-024-00346-1","volume":"44","author":"C Kato","year":"2024","unstructured":"Kato C, Ueda K, Morimoto S, Takahashi S, Nakamura S, Ozawa F, et al. Proteomic insights into extracellular vesicles in ALS for therapeutic potential of Ropinirole and biomarker discovery. Inflamm Regen. 2024;44:32. https:\/\/doi.org\/10.1186\/s41232-024-00346-1.","journal-title":"Inflamm Regen"},{"key":"404_CR32","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.reth.2019.07.002","volume":"11","author":"S Morimoto","year":"2019","unstructured":"Morimoto S, Takahashi S, Fukushima K, Saya H, Suzuki N, Aoki M, et al. Ropinirole hydrochloride remedy for amyotrophic lateral sclerosis \u2013 protocol for a randomized, double-blind, placebo-controlled, single-center, and open-label continuation phase I\/IIa clinical trial (ROPALS trial). Regen Ther. 2019;11:143\u201366. https:\/\/doi.org\/10.1016\/j.reth.2019.07.002.","journal-title":"Regen Ther"},{"key":"404_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41439-022-00217-6","volume":"9","author":"Y Omae","year":"2022","unstructured":"Omae Y, Goto Y-I, Tokunaga K. National center biobank network. Hum Genome Var. 2022;9:38. https:\/\/doi.org\/10.1038\/s41439-022-00217-6.","journal-title":"Hum Genome Var"},{"key":"404_CR34","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen S, Zhou Y, Chen Y, Gu J. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics. 2018;34:i884-90. https:\/\/doi.org\/10.1093\/bioinformatics\/bty560.","journal-title":"Bioinformatics"},{"key":"404_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635.","journal-title":"Bioinformatics"},{"key":"404_CR36","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence alignment\/map format and SAMtools. Bioinformatics. 2009;25:2078\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btp352.","journal-title":"Bioinformatics"},{"key":"404_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37266-6","volume":"14","author":"KC Cotto","year":"2023","unstructured":"Cotto KC, Feng Y-Y, Ramu A, Richters M, Freshour SL, Skidmore ZL, et al. Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer. Nat Commun. 2023;14:1589. https:\/\/doi.org\/10.1038\/s41467-023-37266-6.","journal-title":"Nat Commun"},{"key":"404_CR38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41588-017-0004-9","volume":"50","author":"YI Li","year":"2018","unstructured":"Li YI, Knowles DA, Humphrey J, Barbeira AN, Dickinson SP, Im HK, et al. Annotation-free quantification of RNA splicing using LeafCutter. Nat Genet. 2018;50:151\u20138. https:\/\/doi.org\/10.1038\/s41588-017-0004-9.","journal-title":"Nat Genet"},{"key":"404_CR39","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837\u201345.","journal-title":"Biometrics"}],"container-title":["Inflammation and Regeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41232-026-00404-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41232-026-00404-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41232-026-00404-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:37:24Z","timestamp":1771598244000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41232-026-00404-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["404"],"URL":"https:\/\/doi.org\/10.1186\/s41232-026-00404-w","relation":{},"ISSN":["1880-8190"],"issn-type":[{"value":"1880-8190","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Keio University Hospital (approval No. D18-01) and Keio University School of Medicine (approval No. 20080016), and written informed consent was obtained from the participants. The use of NCNP Biobank samples was approved by the utilization committee (No. NCNPBB-0132) and the ethics committee of the National Center of Neurology and Psychiatry (No. A2012-091).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"HO is a co-founder and CSO of K Pharma, Inc. during the conduct of the study; personal fees from Sanbio Co. Ltd., outside the submitted work. In addition, HO has a patent on a therapeutic agent for amyotrophic lateral sclerosis and a composition for treatment licensed to K Pharma, Inc. The other authors have declared that no conflict of interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}